Patrys Limited

ASX:PAB ISIN:AU000000PAB9

Patrys Limited (ASX:PAB) is an Australia-based company. The principal activity of the Company is to develop natural human antibody based therapeutic products for the treatment of cancer and other diseases. 
 
    

查看其它语言版本

新闻

2010年8月2日澳洲股市

🕔8/2/2010 1:30:45 PM 13028

本周澳洲股市未受华尔街平淡带动的影响，开盘略涨。早盘时，黄金类和金融类股票扬升。基准指数S&P/ASX200 上扬15.2点至4508.7点，综合指数上扬14 点至4521.4点。

阅读全文▸
###

34,198 公司背景浏览

  • 本页浏览人次: (过去7日: 11) (过去30日: 56) (自发布以来: 7234) 

公司详细信息

    主要部门
  • 医疗-制药 
    • 支柱产业
  • None 

更多新闻纪录

  • 2025/04/03: Notification of cessation of securities - PAB*
  • 2025/04/03: Final Director's Interest Notice*
  • 2025/03/31: Retirement of Non-Executive Director*
  • 2025/02/21: Appendix 4D - Half Year Accounts - 31 December 2024*
  • 2025/01/30: Appendix 4C - Quarterly - 31 December 2024*
  • 2024/12/24: Change of Director's Interest Notices x3*
  • 2024/12/24: Notification of cessation of securities - PAB*
  • 2024/12/16: Patrys Receives R&D Tax Incentive Refund*
  • 2024/11/22: Results of Annual General Meeting*
  • 2024/11/22: Chair's Address and CEO Presentation to 2024 AGM*
*refer to company website